Title: Retired Pathologist
Location: Dallas, Texas, United States
Gene E. Ewing, M.D., Retired Pathologist, has been recognized by Marquis Who’s Who Top Doctors for dedication, achievements, and leadership in surgical pathology.
Matriculating at the University of Illinois at Urbana-Champaign, Dr. Ewing received a Bachelor of Science in mathematics and computer science in 1973 and a Bachelor of Science in pre-medicine in 1974. In 1977, he obtained a Doctor of Medicine from the University of Illinois College of Medicine in Chicago. Dr. Ewing subsequently completed a residency in anatomic and clinical pathology, followed by a fellowship in surgical pathology at the University of Minnesota by 1982. From there, the American Board of Pathology certified him in his field.
Dr. Ewing commenced his professional career in 1982 as a partner with ProPath Pathology Services in Dallas, also known as the St. Paul Medical Center. Remaining until 2006, he then joined the University of Texas Southwestern Medical Center as a staff pathologist and faculty member. After devoting one decade to the institution, Dr. Ewing served Arbor Diagnostics as a pathologist from 2017 until officially commenced his retirement in 2019. Reflecting on his illustrious career, he recalls his part-time role as the interim medical director for Wadley Blood Center was particularly memorable. He acknowledges Ron Rosa, Louis Dahner, Stephan Ewing and Jeff McKeller as his greatest motivators and inspirations.
To remain involved in his industry, Dr. Ewing holds membership with the American Association of Blood Banks. With his expansion knowledge, he has contributed to numerous publications over the years, including “False-Positive Sentinel Lymph Nodes in Breast Cancer Patients Caused by Benign Glandular Inclusions: Report of Three Cases and Review of the Literature,” which was featured in the American Journal of Clinical Pathology. He also contributed to “Intraoperative Cytologic Diagnosis of Breast Sentinel Lymph Nodes in the Routine, Nonacademic Setting: A Highly Specific Test with Limited Sensitivity,” which was published in the Breast Journal.
For more information, please visit:
Contact Dr. Ewing: